Santhera Pharmaceuticals Holding AG
SIX:SANN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Santhera Pharmaceuticals Holding AG
SIX:SANN
|
CH |
|
Clear Sale SA
BOVESPA:CLSA3
|
BR |
|
Gke Corporation Ltd
SGX:595
|
SG |
|
Schindler Holding AG
SIX:SCHN
|
CH |
|
P
|
Palatin Technologies Inc
LSE:0KF3
|
US |
|
P
|
Pandora A/S
OTC:PANDY
|
DK |
|
Check Cap Ltd
NASDAQ:CHEK
|
IL |
Wall Street
Price Targets
SANN Price Targets Summary
Santhera Pharmaceuticals Holding AG
According to Wall Street analysts, the average 1-year price target for SANN is 30.6 CHF with a low forecast of 30.3 CHF and a high forecast of 31.5 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SANN's stock price target?
Price Target
30.6
CHF
According to Wall Street analysts, the average 1-year price target for SANN is 30.6 CHF with a low forecast of 30.3 CHF and a high forecast of 31.5 CHF.
What is Santhera Pharmaceuticals Holding AG's Revenue forecast?
Projected CAGR
60%
For the last 13 years the compound annual growth rate for Santhera Pharmaceuticals Holding AG's revenue is 21%. The projected CAGR for the next 3 years is 60%.
